Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of immune-derived molecular markers for coronary heart disease via multimachine learning. | iScience | 2026 | 41782820 | PubTator, text mining | PubMed |
| Brodalumab's 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence. | J Drugs Dermatol | 2026 | 41779761 | PubTator, text mining | PubMed |
| Association of cytokine levels with treatment duration and patient family history in Egyptian multiple sclerosis patients. | Sci Rep | 2026 | 41771986 | PubTator, text mining | PubMed |
| Biologics-induced cutaneous pseudolymphomas: a narrative review with an illustrative case of brodalumab-induced pseudolymphoma. | Drugs Context | 2026 | 41767544 | PubTator, text mining | PubMed |
| Beyond inflammation: metabolic implications of biological and TsDMARD therapies in dermatologic and rheumatologic diseases. | Front Immunol | 2026 | 41766878 | PubTator, text mining | PubMed |
| Biological Treatment of Psoriasis-Data So Far. | Pharmaceuticals (Basel) | 2026 | 41754879 | PubTator, text mining | PubMed |
| Aptamers Targeting IL17A and Its Receptor Suppress IL17 Signaling in Different Cell Types. | Pharmaceuticals (Basel) | 2026 | 41754778 | PubTator, text mining | PubMed |
| Plant-Derived Bioactive Compounds in Inflammation-Related Cancers: Mechanisms and Therapeutic Potential. | Plants (Basel) | 2026 | 41754282 | PubTator, text mining | PubMed |
| Cytokines and Chemokines as Emerging Biomarkers and Therapeutic Targets in Colorectal Cancer-Narrative Review. | Int J Mol Sci | 2026 | 41752132 | PubTator, text mining | PubMed |
| Interleukin-17A Orchestrates Lung Injury and Remodeling Through p53 and uPA System Crosstalk. | Int J Mol Sci | 2026 | 41751974 | PubTator, text mining | PubMed |
| Hedyotis diffusa Suppresses Colitis-Associated Colorectal Cancer via Inhibition of the IL-17A-IL-17RA Axis and NF-κB Signaling. | Int J Mol Sci | 2026 | 41751882 | PubTator, text mining | PubMed |
| Based on single-cell and transcriptome analysis of inflammatory pathway biomarkers and their molecular mechanisms in chronic obstructive pulmonary disease. | PLoS One | 2026 | 41739808 | PubTator, text mining | PubMed |
| Causal association between rheumatoid arthritis and interstitial lung disease: A two-sample bidirectional Mendelian randomization study. | Medicine (Baltimore) | 2026 | 41731788 | PubTator, text mining | PubMed |
| Oxymatrine-associated protection in an MPTP mouse model is accompanied by increased miR-141-3p and reduced HMGB1. | Front Mol Neurosci | 2026 | 41728048 | PubTator, text mining | PubMed |
| Solitary chemosensory cells amplify eosinophilic inflammation via PAR-2 activation in house dust mite-sensitized allergic rhinitis. | World Allergy Organ J | 2026 | 41717077 | PubTator, text mining | PubMed |
| From inflammatory activation to fibrotic remodeling: the central role of macrophage heterogeneity in frozen shoulder. | Front Immunol | 2026 | 41716412 | PubTator, text mining | PubMed |
| Evaluation of 3D biomimetic microcarriers for enhancing therapeutic efficacy of human umbilical cord mesenchymal stem cells in psoriasis treatment. | Front Immunol | 2026 | 41710877 | PubTator, text mining | PubMed |
| The role of human adipose-derived mesenchymal stem cell-derived exosomes in burn injury: a narrative review. | Front Bioeng Biotechnol | 2026 | 41704556 | PubTator, text mining | PubMed |
| Genetic ablation of interleukin-17A augments fibrosis in a mouse model of cholestatic liver injury. | PLoS One | 2026 | 41650211 | PubTator, text mining | PubMed |
| Microbiota in cancer: current understandings and future perspectives. | Signal Transduct Target Ther | 2026 | 41629271 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=4